IPO Boutique

Castle Creek Biosciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Castle Creek Biosciences, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Castle Creek Biosciences, Inc.CCBS -
NASDAQ
TBD $0.00 $0.00TBD
Citigroup, Piper Sandler, Barclays
Co-Manager(s):
Canaccord Genuity
Health Care
Filing(s):

Filed 2021-07-16



About Castle Creek Biosciences, Inc. (adapted from Castle Creek Biosciences, Inc. prospectus):
They are a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CCBS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved